Prostate-specific membrane antigen in circulating tumor cells is a new poor prognostic marker for castration-resistant prostate cancer | PLOS ONE
Measurement of total and free prostate specific antigen (PSA) in human serum samples using an ultra-microanalytical system - ScienceDirect
Improving the diagnosis of prostate cancer by telomerase-positive circulating tumor cells: A prospective pilot study - eClinicalMedicine
Explaining PSA Numbers
Understanding PSA Levels & The PSA Test | HALO Precision Diagnostics
PSA-NCAM Monoclonal Antibody (12E3) (14-9118-82)
Novinky v léčbě kastračně rezistentního karcinomu prostaty
Prostate PSA Test | PRIMA Lab SA
The Paradox of a Man's Most-Feared Test, the PSA | The MIT Press Reader
The Great Prostate Hoax: How Big Medicine Hijacked the PSA Test and Caused a Public Health Disaster: Ablin, Richard J., Piana, Ronald: 9781137278746: Amazon.com: Books
Highly portable quantitative screening test for prostate-specific antigen at point of care - ScienceDirect
What is a prostate health index test? - Phi Results
image001.jpg
Prostate Specific Antigen (PSA); ≥99% pure - liquid - scrippslabs.com
The neuroplasticity marker PSA-NCAM: Insights into new therapeutic avenues for promoting neuroregeneration - ScienceDirect
Perspective on PSA Testing - Desert Medical Imaging
The PSA Test and Screening | Prostate Cancer Foundation
Biochemical recurrence after radical prostatectomy according to nadir prostate specific antigen value | PLOS ONE
To PSA test or not to PSA test: That is the discussion - Harvard Health
Falling PSA levels found to predict longer survival in prostate cancer patients at high risk of metastases
Lokalizovaný karcinom prostaty – diagnostika a léčba
How to deal with non-specificity of tumor markers?
Identification of Multisialylated LacdiNAc Structures as Highly Prostate Cancer Specific Glycan Signatures on PSA | Analytical Chemistry
Current clinical utility of prostate cancer markers
